glp 1 bile acid malabsorption Remission of Symptoms Following Treatment With the Glucagon-Like Peptide Receptor Agonist Liraglutide GLP-1 and Microbiome Repair for

Given the intractable pediatric obesity epidemic and associated rise in type 2 diabetes in youth, made worse by the COVID-19 pandemic related shutdowns and disruptions in opportunities for exercise and play in youth, this new class of medications will certainly benefit children with morbid obesity and type 2 diabetes

Biessels GJ, De Leeuw FE, Lindeboom J, Barkhof F, Scheltens P

Their dual effects on weight and alcohol consumption highlight the shared biology underlying metabolic and addictive disorders

The C18 fatty diacid side chain must be synthesized separately and then chemically conjugated to a specific lysine residue on the peptide backbone through a glutamic acid linker